Christophe Arbet-Engels - Chief Medical Officer at X4 Pharmaceuticals, Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
XFOR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christophe Arbet-Engels since 05 Feb 2025

Holdings reported by Christophe Arbet-Engels for X4 Pharmaceuticals, Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 864,207 $392,350 $0.4540 12 Feb 2025 Direct
Stock Appreciation Right 180,816 13 Feb 2024 Direct Common Stock

Transactions reported by Christophe Arbet-Engels for X4 Pharmaceuticals, Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.